These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27057577)

  • 21. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a urinary-specific antibiogram for gram-negative isolates: impact of patient risk factors on susceptibility.
    Rabs N; Wieczorkiewicz SM; Costello M; Zamfirova I
    Am J Infect Control; 2014 Apr; 42(4):393-400. PubMed ID: 24559594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
    Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
    Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of emergency department to hospital antibiograms: Influence of patient risk factors on susceptibility.
    Miller JL; George A; Kozmic SE; Beganovic M; Wieczorkiewicz SM
    Am J Emerg Med; 2020 Jun; 38(6):1153-1158. PubMed ID: 31495521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa.
    Brink A; Moolman J; da Silva MC; Botha M;
    S Afr Med J; 2007 Apr; 97(4):273-9. PubMed ID: 17446952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial resistance in 11 hospitals in Puerto Rico: results of an antimicrobial resistance management (ARM) program.
    Gums JG; Boatwright DW; Totti N; Martinez M
    P R Health Sci J; 2007 Sep; 26(3):181-9. PubMed ID: 18035809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial spectrum and resistance patterns in endophthalmitis: a 21-year (1988-2008) review in northeast United States.
    Chen X; Adelman RA
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):329-34. PubMed ID: 22506856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in fluoroquinolone resistance over 5 years (CANWARD 2007-11) in bacterial pathogens isolated in Canadian hospitals.
    Karlowsky JA; Adam HJ; Desjardins M; Lagacé-Wiens PR; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i39-46. PubMed ID: 23587777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biological activity of antibacterial substance produced by Enterobacter cloacae B8.
    Ya-Ping J; Wei-liang C; Rong Z; Bai-rong Z
    Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2003; 13(2):115-20. PubMed ID: 14509942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbial uropathogens and their antibiotic resistance profile from hospitalized patients in Central Alabama.
    Qian L; Camara T; Taylor JK; Jones KW
    Clin Lab Sci; 2012; 25(4):206-11. PubMed ID: 23330509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surveillance of bacterial distribution and drug resistance in inpatients with surgical infections: a single center study].
    Jiang KW; Lü Y; Guo P; Ye YJ; Wang H; Wang Q; Zhao CJ; Gao ZD; Cao J; Lü L; Yan YC; Wang S
    Zhonghua Wai Ke Za Zhi; 2013 Jul; 51(7):604-9. PubMed ID: 24256585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
    Gebre-Sealsssie S
    Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011).
    Biedenbach DJ; Bouchillon SK; Hoban DJ; Hackel M; Phuong DM; Nga TT; Phuong NT; Phuong TT; Badal RE
    Diagn Microbiol Infect Dis; 2014 Aug; 79(4):463-7. PubMed ID: 24923210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K; Kadota J; Aoki N; Matsumoto T; Yoshida M; Yagisawa M; Oguri T; Sato J; Ogasawara K; Wakamura T; Sunakawa K; Watanabe A; Iwata S; Kaku M; Hanaki H; Ohsaki Y; Watari T; Toyoshima E; Takeuchi K; Shiokoshi M; Takeda H; Miki M; Kumagai T; Nakanowatari S; Takahashi H; Utagawa M; Nishiya H; Kawakami S; Kobayashi N; Takasaki J; Mezaki K; Konosaki H; Aoki Y; Yamamoto Y; Shoji M; Goto H; Saraya T; Kurai D; Okazaki M; Niki Y; Yoshida K; Kawana A; Saionji K; Fujikura Y; Miyazawa N; Kudo M; Sato Y; Yamamoto M; Yoshida T; Nakamura M; Tsukada H; Imai Y; Tsukada A; Kawasaki S; Honma Y; Yamamoto T; Ban N; Mikamo H; Sawamura H; Miyara T; Toda H; Sato K; Nakamura T; Fujikawa Y; Mitsuno N; Mikasa K; Kasahara K; Sano R; Sugimoto K; Asari S; Nishi I; Toyokawa M; Miyashita N; Koguchi Y; Kusano N; Mihara E; Kuwabara M; Watanabe Y; Kawasaki Y; Takeda K; Tokuyasu H; Masui K; Negayama K; Hiramatsu K; Aoki Y; Fukuoka M; Magarifuchi H; Nagasawa Z; Suga M; Muranaka H; Morinaga Y; Honda J; Fujita M
    J Infect Chemother; 2015 Jun; 21(6):410-20. PubMed ID: 25817352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceftaroline activity tested against bacterial isolates from pediatric patients: results from the assessing worldwide antimicrobial resistance and evaluation program for the United States (2011-2012).
    Sader HS; Mendes RE; Farrell DJ; Flamm RK; Jones RN
    Pediatr Infect Dis J; 2014 Aug; 33(8):837-42. PubMed ID: 25222304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
    Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
    Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.